Latest HBV Stories
- Proceeds to Support Phase II Clinical Development of SB 9200 Against Hepatitis B - MILFORD, Mass., Feb.
PARIS, February 26, 2015 /PRNewswire/ -- ABIVAX, a clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, today announced
Receives Notice of Allowance for Composition of Matter Patent Extending Exclusivity Coverage to at least 2031 EDISON, N.J., Feb.
EDISON, N.J., Jan. 20, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.
DOYLESTOWN, Pa., Jan.
DOYLESTOWN, Pa., Nov.
Phase 1b Clinical Studies Ongoing in Patients with Chronic HBV Infection DOYLESTOWN, Pa., Nov.
Presented: Sunday, November 9, 2014, 5:00 pm Eastern - Hynes Convention Center, Boston, MA BOSTON, Nov.
MILFORD, Mass., Sept.
Pharmacokinetics, Safety and Tolerability of NVR-1221 Support Advancement to Phase 1b Clinical Studies in Patients with Chronic HBV Infection DOYLESTOWN, Pa., Sept.
- The parings of haberdine; also, any kind of fragments.